Effectiveness of 0.1% mometasone furoate under hydrocolloid dressing versus 0.1% mometasone furoate in patients with lichen simplex chronicus. [PDF]
Skin Health Dis, 2023 There was a lack of high‐quality, evidence‐based treatment for lichen simplex chronicus (LSC). Topical steroid under hydrocolloid dressing treatment was investigated mostly in observational studies without investigation of the cost‐effectiveness and the ...
Lo HL, Ip FC.
europepmc +4 more sources
Multi-Gram Scale Synthesis and Characterization of Mometasone Furoate EP Impurity C. [PDF]
Molecules, 2023 Mometasone furoate is a synthetic corticosteroid used in the treatment of skin inflammatory conditions, hay fever and asthma. The industrial manufacturing routes to mometasone furoate are generally accompanied by the formation of numerous process ...
Ronchetti R +6 more
europepmc +2 more sources
New Vehiculation Systems of Mometasone Furoate for the Treatment of Inflammatory Skin Diseases. [PDF]
Pharmaceutics, 2022 A pre-formulation study was carried out to obtain liposomal formulations of mometasone furoate as an alternative system to marketed forms of corticosteroid for the treatment of inflammatory skin lesions.
Taléns-Visconti R +3 more
europepmc +2 more sources
The efficacy of topical 0.1% mometasone furoate for treating symptomatic severe phimosis: A comparison of two treatment regimens. [PDF]
Front Pediatr, 2022 BackgroundTwice daily 0.1% mometasone furoate is an effective treatment for phimosis in children. However, mometasone furoate has an important therapeutic advantage because it is effective in once-daily applications.
Zhou G +5 more
europepmc +2 more sources
Efficacy and safety of combined loratadine and mometasone furoate therapy in allergic rhinitis patients. [PDF]
Front ImmunolObjectiveThis study seeks to assess the effectiveness and safety of a combination treatment involving loratadine and mometasone furoate for patients suffering from allergic rhinitis (AR).
Yong H +5 more
europepmc +2 more sources
Mometasone furoate nasal spray: a systematic review [PDF]
Multidisciplinary Respiratory Medicine, 2016 The inflammatory diseases of the nose, rhino-pharynx and paranasal sinuses (allergic and non allergic rhinitis, NARES; rhinosinusitis with/without nasal polyposis, adenoidal hypertrophy with/without middle ear involvement) clinically manifest themselves with symptoms and complications severely affecting quality of life and health care expenditure ...
Passali, Desiderio +3 more
core +5 more sources
Efficacy of Mometasone Furoate and Fluticasone Furoate on Persistent Allergic Rhinoconjunctivitis [PDF]
Allergy & Rhinology, 2013 Allergic rhinoconjunctivitis denotes both nasal and ocular manifestation of allergy, which may be solely treated with intranasal steroid. This study compares the efficacy of mometasone furoate nasal spray (NS) and fluticasone furoate NS in treatment of ...
W. Hamizan Aneeza M.S. +5 more
doaj +3 more sources
Mometasone furoate is not superior to saline for chronic rhinitis in the elderly. [PDF]
World Allergy Organ J, 2019 Introduction: Prevalence of diseases associated with ageing is rising; among these are the rhinologic problems. Chronic rhinitis appears as one of the most common worrisome nasal disorders in this age group. At the same time, the allergic form diminishes
Carvalho V +3 more
europepmc +2 more sources
Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/ indacaterol/glycopyrronium in patients with asthma [PDF]
Pulmonary Pharmacology & Therapeutics, 2021 Once-daily (o.d.) fixed-dose combinations of mometasone furoate/indacaterol acetate and mometasone furoate/indacaterol acetate/glycopyrronium bromide, both delivered via the Breezhaler® device, are approved for the maintenance treatment of asthma. Across
Bartels, Christian +7 more
core +3 more sources
In perennial allergic rhinitis, RQLQ is improved similarly by Azelastine 0.15 and mometasone furoate. [PDF]
World Allergy Organ JSome double-blind, placebo-controlled trials have shown that Azelastine (Aze) high dose (0.15%) was effective in seasonal (SAR) and perennial allergic rhinitis (PAR).
Bousquet J +6 more
europepmc +2 more sources